|
Originally published In Press as doi:10.1074/jbc.M212892200 on April 13, 2003
J. Biol. Chem., Vol. 278, Issue 26, 23738-23746, June 27, 2003
Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane*
Bruce D. Wyse ,
Ian A. Prior ,
Hongwei Qian ¶,
Isabel C. Morrow ||,
Susan Nixon ||,
Cornelia Muncke ,
Teymuras V. Kurzchalia **,
Walter G. Thomas ¶,
Robert G. Parton || and
John F. Hancock 
From the
Institute for Molecular Bioscience, the
Department of Molecular and Cellular Pathology,
and the ||Centre for Microscopy and Microanalysis
and School of Biomedical Sciences, University of Queensland, Brisbane, 4072
Queensland, Australia, the ¶Baker Heart Research
Institute, Melbourne, 3004 Victoria, Australia, and the
**Max Planck Institute for Molecular Cell Biology and
Genetics, Dresden D-01307, Germany
The mechanisms involved in angiotensin II type 1 receptor
(AT1-R) trafficking and membrane localization are largely unknown.
In this study, we examined the role of caveolin in these processes. Electron
microscopy of plasma membrane sheets shows that the AT1-R is not
concentrated in caveolae but is clustered in cholesterol-independent
microdomains; upon activation, it partially redistributes to lipid rafts.
Despite the lack of AT1-R in caveolae,
AT1-R·caveolin complexes are readily detectable in cells
co-expressing both proteins. This interaction requires an intact caveolin
scaffolding domain because mutant caveolins that lack a functional caveolin
scaffolding domain do not interact with AT1-R. Expression of an
N-terminally truncated caveolin-3, CavDGV, that localizes to lipid bodies, or
a point mutant, Cav3-P104L, that accumulates in the Golgi mislocalizes
AT1-R to lipid bodies and Golgi, respectively. Mislocalization
results in aberrant maturation and surface expression of AT1-R,
effects that are not reversed by supplementing cells with cholesterol.
Similarly mutation of aromatic residues in the caveolin-binding site abrogates
AT1-R cell surface expression. In cells lacking caveolin-1 or
caveolin-3, AT1-R does not traffic to the cell surface unless
caveolin is ectopically expressed. This observation is recapitulated in
caveolin-1 null mice that have a 55% reduction in renal AT1-R
levels compared with controls. Taken together our results indicate that a
direct interaction with caveolin is required to traffic the AT1-R
through the exocytic pathway, but this does not result in AT1-R
sequestration in caveolae. Caveolin therefore acts as a molecular chaperone
rather than a plasma membrane scaffold for AT1-R.
Received for publication, December 18, 2002
, and in revised form, April 8, 2003.
* This work is supported by grants from the National Health and Medical
Research Council of Australia (to J. F. H. and R. G. P.) and Queensland Cancer
Fund (to J. F. H.). The Institute for Molecular Bioscience is a Special
Research Center of the Australian Research Council. The costs of publication
of this article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 61-7-3346-2033; Fax:
61-7-3346-2101; E-mail:
j.hancock{at}mailbox.uq.edu.au.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Fujita, J. Cheng, K. Tauchi-Sato, T. Takenawa, and T. Fujimoto
A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling technique
PNAS,
June 9, 2009;
106(23):
9256 - 9261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, R. H. Henning, M. Sandovici, J. J. van der Want, W. H. van Gilst, and H. Buikema
Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function
Eur J Heart Fail,
March 1, 2009;
11(3):
246 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Nagami, J. A. Chang, M. E. Plato, and R. Santamaria
Acid loading in vivo and low pH in culture increase angiotensin receptor expression: enhanced ammoniagenic response to angiotensin II
Am J Physiol Renal Physiol,
December 1, 2008;
295(6):
F1864 - F1870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fekete, K. Rosta, L. Wagner, A. Prokai, P. Degrell, E. Ruzicska, E. Vegh, M. Toth, K. Ronai, K. Rusai, et al.
Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney - another reason for diabetic nephropathy?
J. Physiol.,
November 15, 2008;
586(22):
5337 - 5348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Szaszak, H.-D. Chen, H.-C. Chen, A. Baukal, L. Hunyady, and K. J Catt
Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein
J. Endocrinol.,
November 1, 2008;
199(2):
165 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hernandez-Deviez, M. T. Howes, S. H. Laval, K. Bushby, J. F. Hancock, and R. G. Parton
Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin
J. Biol. Chem.,
March 7, 2008;
283(10):
6476 - 6488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. McEwen, Q. Li, S. Jackson, P. M. Jenkins, and J. R. Martens
Caveolin Regulates Kv1.5 Trafficking to Cholesterol-Rich Membrane Microdomains
Mol. Pharmacol.,
March 1, 2008;
73(3):
678 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Langlois, K. N. Cowan, Q. Shao, B. J. Cowan, and D. W. Laird
Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes
Mol. Biol. Cell,
March 1, 2008;
19(3):
912 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alioua, R. Lu, Y. Kumar, M. Eghbali, P. Kundu, L. Toro, and E. Stefani
Slo1 Caveolin-binding Motif, a Mechanism of Caveolin-1-Slo1 Interaction Regulating Slo1 Surface Expression
J. Biol. Chem.,
February 22, 2008;
283(8):
4808 - 4817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mendez-Bolaina, J. Sanchez-Gonzalez, I. Ramirez-Sanchez, E. Ocharan-Hernandez, M. Nunez-Sanchez, E. Meaney-Mendiolea, A. Meaney, J. Asbun-Bojalil, A. Miliar-Garcia, I. Olivares-Corichi, et al.
Effect of caveolin-1 scaffolding peptide and 17 -estradiol on intracellular Ca2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells
Am J Physiol Cell Physiol,
December 1, 2007;
293(6):
C1953 - C1961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. C. Kong, A. Hasbi, M. Mattocks, T. Fan, B. F. O'Dowd, and S. R. George
Regulation of D1 Dopamine Receptor Trafficking and Signaling by Caveolin-1
Mol. Pharmacol.,
November 1, 2007;
72(5):
1157 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Gonzalez, E. Krizman-Genda, and M. B. Robinson
Caveolin-1 Regulates the Delivery and Endocytosis of the Glutamate Transporter, Excitatory Amino Acid Carrier 1
J. Biol. Chem.,
October 12, 2007;
282(41):
29855 - 29865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Linder, K. M. Thakali, J. M. Thompson, S. W. Watts, R. C. Webb, and R. Leite
Methyl-beta-cyclodextrin Prevents Angiotensin II-Induced Tachyphylactic Contractile Responses in Rat Aorta
J. Pharmacol. Exp. Ther.,
October 1, 2007;
323(1):
78 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shmuel, E. Nodel-Berner, T. Hyman, A. Rouvinski, and Y. Altschuler
Caveolin 2 Regulates Endocytosis and Trafficking of the M1 Muscarinic Receptor in MDCK Epithelial Cells
Mol. Biol. Cell,
May 1, 2007;
18(5):
1570 - 1585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol.,
December 1, 2006;
20(12):
3400 - 3411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ushio-Fukai and R. W. Alexander
Caveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle
Hypertension,
November 1, 2006;
48(5):
797 - 803.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Drake, S. K. Shenoy, and R. J. Lefkowitz
Trafficking of G Protein-Coupled Receptors
Circ. Res.,
September 15, 2006;
99(6):
570 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Kilianova, N. Basora, P. Kilian, M. D. Payet, and N. Gallo-Payet
Human Melanocortin Receptor 2 Expression and Functionality: Effects of Protein Kinase A and Protein Kinase C on Desensitization and Internalization
Endocrinology,
May 1, 2006;
147(5):
2325 - 2337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Martin
Caveolae and cell swelling. Focus on "Stimulation by caveolin-1 of the hypotonicity-induced release of taurine and ATP at basolateral, but not apical, membrane of Caco-2 cells"
Am J Physiol Cell Physiol,
May 1, 2006;
290(5):
C1273 - C1274.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Parton, M. Hanzal-Bayer, and J. F. Hancock
Biogenesis of caveolae: a structural model for caveolin-induced domain formation.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
787 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Mora, V. L. Bonilha, B.-C. Shin, J. Hu, L. Cohen-Gould, D. Bok, and E. Rodriguez-Boulan
Bipolar assembly of caveolae in retinal pigment epithelium
Am J Physiol Cell Physiol,
March 1, 2006;
290(3):
C832 - C843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hernandez-Deviez, S. Martin, S. H. Laval, H. P. Lo, S. T. Cooper, K. N. North, K. Bushby, and R. G. Parton
Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3
Hum. Mol. Genet.,
January 1, 2006;
15(1):
129 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Manninen, P. Verkade, S. Le Lay, J. Torkko, M. Kasper, J. Fullekrug, and K. Simons
Caveolin-1 Is Not Essential for Biosynthetic Apical Membrane Transport
Mol. Cell. Biol.,
November 15, 2005;
25(22):
10087 - 10096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Gratton, P. Bernatchez, and W. C. Sessa
Caveolae and Caveolins in the Cardiovascular System
Circ. Res.,
June 11, 2004;
94(11):
1408 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Attia, O. Feron, R. Goldschmeding, L. H. Radermakers, N. D. Vaziri, P. Boer, J.-L. Balligand, H. A. Koomans, and J. A. Joles
Hypercholesterolemia in Rats Induces Podocyte Stress and Decreases Renal Cortical Nitric Oxide Synthesis via an Angiotensin II Type 1 Receptor-Sensitive Mechanism
J. Am. Soc. Nephrol.,
April 1, 2004;
15(4):
949 - 957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|